Continuing Education Activity
Celiac disease, also known as gluten-sensitive enteropathy, is an autoimmune disease of the small intestine. Celiac disease is a condition in which the body responds to gluten with an inappropriate immune response causing small intestinal inflammation and damage. This activity illustrates the evaluation and management of celiac disease and reviews the role of the interprofessional team in improving care for patients with this condition.
Objectives:
Review the pathophysiology of celiac disease.
Summarize the treatment of celiac disease.
Describe the evaluation of a patient suspected of having celiac disease.
Outline the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by celiac disease.
Introduction
Celiac disease is an enteropathy of the small intestine. It is triggered by exposure to gluten in the diet of susceptible people. The susceptibility is genetically determined. The condition is chronic, and currently,the only treatment consists of permanent exclusion of gluten from the food intake.[1][2][3]
Patients with celiac disease can present with diarrhea and failure to thrive; some may be asymptomatic.
Etiology
The symptoms of celiac disease are due to the damage of enterocytes in the small intestine. In the full-blown clinical picture, the typical features of the small intestine are chronic inflammation and villi atrophy.[4][5][4]
An individual has to have HLA dominant DQ2 or DQ8 genes. The disease is a result of the immune system reacting adversely to gluten, and one of the important proteins involved is an antibody to tissue transglutaminase. There are however other pathways proposed that contribute to the disease. The glycoprotein gliadin (present in gluten) has adirect toxic effect on enterocytes by the up-regulating production of IL-15.
Some studies indicate that gastrointestinal infections in early childhood are relevant to the development of celiac disease later in life. This is not surprising considering the organ affected, but it is likely that is also directly relevant to the fact that celiac disease is caused by a disorder of immune function.
IgA antibodies to smooth muscle endomysium and tissue transglutaminase are often used to make the diagnosis of celiac disease. However, only about 5% of patients with celiac disease have a deficiency of this immunoglobulin.
Epidemiology
The prevalence of celiac disease in the general population is about 0.5% to 1%. Both true prevalence, as well as detection and diagnosis, have increased over the past 10 to 20 years. The incidence is greater among people with autoimmune disorders like type 1 diabetes. In first-degree relatives of people affected by celiac disease, the risk is 1 in 10.
Pathophysiology
A peptide derived from gluten called gliadin causes damage to the small intestine. There is local inflammation, and the process leads to the destruction of the small intestinal villi. Thisdestruction, in turn, leads to the decreased functionality of the intestinal surface and malabsorption. The lack of nutrient absorption impacts directly on the digestive system but also indirectly on all the systems of the body. Thisimpact results in generallypoor health and is the reason whyceliac disease can have signs and symptoms arising from almost any system of the body, not just the gastrointestinal system.[6]
Histopathology
Celiac disease only involves the mucosa of the small bowel. The villi may be absent or atrophic and the crypt hyperplasia is present. An increased proliferation of lymphocytes and plasma cells is seen in the lamina propria.
Toxico*kinetics
There has been long-standing doubt about the toxicity of oats for a patient with celiac disease. Recently, studies have shown that oats are not harmful, and any doubts were likely because it is commonly processed together with wheat and therefore, cross-contamination was veryhigh.
History and Physical
The common symptoms are lethargy and diarrhea hence the name celiac sprue. Other gastrointestinal symptoms are abdominal distension, discomfort or pain, vomiting, and constipation. In childhood, failure to thrive is an important aspect of the history, while in adulthood the corresponding symptom would be unexplained weight loss. Symptoms from other than gastrointestinal systems include recurrent aphthous ulcers in the mouth, iron deficiency anemia, ataxia, chronic headaches, and delayed menarche.The incidence of some obstetric complications such aspreterm labor, growth restriction, and stillbirth in women with the untreated celiac disease is higher.
Dermatitis herpetiformis is a skin condition caused by gluten intolerance, and just like the enteropathy it usually responds to the exclusion of gluten from the diet.
Extraintestinal symptoms are common and may include:
Anemia due to defective absorption of vitamin B12, folate or iron
Coagulopathy due to impaired absorption of vitamin K
Osteoporosis
Neurological symptoms like muscle weakness, paresthesias, seizures and ataxia
Evaluation
Diagnostic workup usually starts with serological tests. The two antibodies measured are anti-tissue transglutaminase antibodies (by enzyme-linked immunosorbent assay or ELISA measured numerically) and anti-endomysial antibodies that areusually reported as negative, weakly positive or positive. Traditionally, the next step and the gold standard for the diagnosis is duodenal mucosal biopsy; in celiac disease, this shows villous atrophy. It is important that these tests be performed while the patient is on a regular, gluten-containing diet.[7][8]
Another useful test is for human leukocyte antigen (HLA). Specific HLA genotypes have been strongly associated with celiac disease. HLA testing can be used in the diagnostic process. For example, Joint BSPGHAN and Celiac UK guidelines published in 2013 indicates that positive serological tests with positive HLA typing in the presence of typical symptoms can be accepted as confirmative of diagnosis without a need for biopsy.
Laboratory studies:
Both type 1 diabetics and down syndrome have a high incidence of celiac disease; so appropriate workup is required
Electrolytes may reveal hypocalcemia, hypokalemia, metabolic acidosis
Anemia due to deficiency of folate, iron or Vit B12
Prothrombin time may be prolonged
Stool are greasy and have a rancid odor
Radiology
Small bowel follow-through may reveal obliteration of intestinal mucosa, bowel dilatation and flocculation of the barium.
Upper endoscopy is often used to confirm the diagnosis
Treatment / Management
It is recommended that all people diagnosed with celiac disease follow a strict gluten-free diet. Thisadherenceis best done under the supervision of specialists, including a dietician. In general, symptoms improve on the gluten-free diet within days to weeks. Unresponsive patients need further review of the diagnosis but also an assessment of compliance with the diet. Serology testing can assess compliance. Non-compliance can be unintentional inan individual who may be still ingesting gluten without realizing it.[9][10]
Other tests include looking at the impact of malabsorption (due to celiac disease). The following can be monitored: full blood count, iron stores, folate, ferritin, levels of vitamin D and other fat-soluble vitamins, and bone mineral density.
Management of patients with positive serology but no abnormal findings on biopsy on duodenal biopsy is controversial. There are many situations when the diagnosis is not clear-cut. Some patients experience relevant symptoms in spite of no identified changes on small gut biopsy. There is also seronegative celiac disease. This term describes the reverse situation when in spite of typical symptoms there is no serological evidence of the disease, but there is significant villous atrophy of duodenal biopsy.
Currently, the only recommended treatment for celiac disease is the gluten-free diet. Thismakesa significant impact on the lives of people affected and can be challenging to maintain. There is continuous work on possiblenon-dietary therapies that enable people with celiac disease to tolerate gluten. One of the main focuses of the research in this area is immune modulators. Other approaches, like immunizations or ingesting substances that would change the toxicity of gluten are also being explored. However, none have reached the stage of being recommended or approved for such therapy.
Corticosteroids only benefit a small percentage of patients with celiac disease.
Differential Diagnosis
Bacterialgastroenteritis
Crohn disease
Giardia
Irritable Bowel syndrome
Malabsorption
Viral gastroenteritis
Prognosis
The prognosis for patients with the correct diagnosis and treatment is good. Unfortunately, compliance with a gluten-free diet is very difficult and relapses are common. Some patients do not respond to a gluten-free diet or corticosteroids; they have a poor quality of life.
Complications
There is a risk of lymphomas and small bowel adenocarcinomas of the small bowel in the long run.
Pregnant women may have a miscarriage and/or have an infant with congenital birth defects
Short statureand failure to thrive can occur in children
Failure to absorb the nutrients can lead tothe following:
Osteopenia
Bleeding diathesis
Stunted growth
Anemia
Lack of exercise endurance
Seizures
Postoperative and Rehabilitation Care
Once the diagnosis of celiac disease is made, patents need regular follow up to ensure that they are compliant with a gluten-freediet and not developing any complications.
Deterrence and Patient Education
Patient should remain compliant with a gluten-freediet
Pearls and Other Issues
The untreated coeliac disease leads to chronic ill health and complications. Secondary lactose intolerance is common. There is increased the risk of osteoporosis, epilepsy, infections and bowel cancer and jejunal lymphoma. Lack of calcium leads to problems with dentition.
Because celiac disease is an autoimmune disease, many clinicians recommend that all patients with celiac disease should also be screened for type 1 diabetes and thyroid function problems. Thisscreeningis recommendedbecause similar autoimmune disturbances are at the root of these disorders and therefore, there is increased the risk of these disorders in people who share the common genetic background.
Enhancing Healthcare Team Outcomes
The number of cases of celiac disease has gone up in the last three decades. In fact, the disease is initially often mistaken for irritable bowel syndrome, and the diagnosis is delayed for months or years. Celiac disease can have significant complications if it is not treated and hence, an interprofessional team approach to diagnosis and treatment is necessary. Most patients initially present to the nurse practitioner, pediatrician or primary care provider with complaints of diarrhea and abdominal pain.
If the disorder is suspected a gastroenterologist should be consulted. Once the disease is confirmed, patients are generally managed as outpatients. Nurses play a vital role in the monitoring of these patients for complications and compliance with the diet. A dietary consult is highly recommended as these patients need to know the importance of a gluten-free diet.
Further, children will need to be monitored for stunted growth and failure to thrive.[11][12](Level V)
Several national guidelines have recommended an interprofessional approach to celiac disease as it can involve many organs in the body. New evidence reveals that these patients may be prone to a high rate of fractures and hence, bone scanning should be performed.
Comprehensive nutritional managementis requiredwith an interprofessional approach to treatment. The nurse should monitor patients for refractoriness to treatment because these patients may require corticosteroids. In addition, all healthcare workers who look after celiac patients should be aware that the disorder can cause lymphomas and adenocarcinomas of the intestine at some point. Further, celiac disease is also associated with psychiatric illness, depression, and infertility.[13][Level5]
Outcomes
The prognosis for patients who are diagnosed early and remain compliant with their gluten-free diet is excellent. However, there are somepatients who do not respond well to a gluten-free diet, and they may require steroids. The prognosis for these patients is guarded.[14][15]
Figure
Fig 1: Intestinal changes of Celiac disease. Reproduced with permission from GeneFood.
Figure
Very high magnification micrograph of celiac disease. H&E stain From Wikimedia Commons, by user Nephron (CC BY-SA 3.0 https://creativecommons.org/licenses/by-sa/3.0/)
References
- 1.
Yu XB, Uhde M, Green PH, Alaedini A. Autoantibodies in the Extraintestinal Manifestations of Celiac Disease. Nutrients. 2018 Aug 20;10(8) [PMC free article: PMC6115844] [PubMed: 30127251]
- 2.
Clark R, Johnson R. Malabsorption Syndromes. Nurs Clin North Am. 2018 Sep;53(3):361-374. [PubMed: 30100002]
- 3.
Sharma P, Baloda V, Gahlot GP, Singh A, Mehta R, Vishnubathla S, Kapoor K, Ahuja V, Gupta SD, Makharia GK, Das P. Clinical, endoscopic, and histological differentiation between celiac disease and tropical sprue: A systematic review. J Gastroenterol Hepatol. 2019 Jan;34(1):74-83. [PubMed: 30069926]
- 4.
Savvateeva LV, Erdes SI, Antishin AS, Zamyatnin AA. Current Paediatric Coeliac Disease Screening Strategies and Relevance of Questionnaire Survey. Int Arch Allergy Immunol. 2018;177(4):370-380. [PubMed: 30056445]
- 5.
McAllister BP, Williams E, Clarke K. A Comprehensive Review of Celiac Disease/Gluten-Sensitive Enteropathies. Clin Rev Allergy Immunol. 2019 Oct;57(2):226-243. [PubMed: 29858750]
- 6.
do Vale RR, Conci NDS, Santana AP, Pereira MB, Menezes NYH, Takayasu V, Laborda LS, da Silva ASF. Celiac Crisis: an unusual presentation of gluten-sensitive enteropathy. Autops Case Rep. 2018 Jul-Sep;8(3):e2018027. [PMC free article: PMC6066267] [PubMed: 30101133]
- 7.
Glissen Brown JR, Singh P. Coeliac disease. Paediatr Int Child Health. 2019 Feb;39(1):23-31. [PubMed: 30099930]
- 8.
Bai JC, Ciacci C. World Gastroenterology Organisation Global Guidelines: Celiac Disease February 2017. J Clin Gastroenterol. 2017 Oct;51(9):755-768. [PubMed: 28877080]
- 9.
Walker MM, Ludvigsson JF, Sanders DS. Coeliac disease: review of diagnosis and management. Med J Aust. 2017 Aug 21;207(4):173-178. [PubMed: 28814219]
- 10.
Werkstetter KJ, Korponay-Szabó IR, Popp A, Villanacci V, Salemme M, Heilig G, Lillevang ST, Mearin ML, Ribes-Koninckx C, Thomas A, Troncone R, Filipiak B, Mäki M, Gyimesi J, Najafi M, Dolinšek J, Dydensborg Sander S, Auricchio R, Papadopoulou A, Vécsei A, Szitanyi P, Donat E, Nenna R, Alliet P, Penagini F, Garnier-Lengliné H, Castillejo G, Kurppa K, Shamir R, Hauer AC, Smets F, Corujeira S, van Winckel M, Buderus S, Chong S, Husby S, Koletzko S., ProCeDE study group. Accuracy in Diagnosis of Celiac Disease Without Biopsies inClinical Practice. Gastroenterology. 2017 Oct;153(4):924-935. [PubMed: 28624578]
- 11.
Paul SP, Harries SL, Basude D. Barriers to implementing the revised ESPGHAN guidelines for coeliac disease in children: a cross-sectional survey of coeliac screen reporting in laboratories in England. Arch Dis Child. 2017 Oct;102(10):942-946. [PubMed: 28483757]
- 12.
Laurikka P, Nurminen S, Kivelä L, Kurppa K. Extraintestinal Manifestations of Celiac Disease: Early Detection for Better Long-Term Outcomes. Nutrients. 2018 Aug 03;10(8) [PMC free article: PMC6115849] [PubMed: 30081502]
- 13.
Pekki H, Kaukinen K, Ilus T, Mäki M, Huhtala H, Laurila K, Kurppa K. Long-term follow-up in adults with coeliac disease: Predictors and effect on health outcomes. Dig Liver Dis. 2018 Nov;50(11):1189-1194. [PubMed: 30025706]
- 14.
Haridy J, Lewis D, Newnham ED. Investigational drug therapies for coeliac disease - where to from here? Expert Opin Investig Drugs. 2018 Mar;27(3):225-233. [PubMed: 29411655]
Disclosure: Ewa Posner declares no relevant financial relationships with ineligible companies.
Disclosure: Muhammad Haseeb declares no relevant financial relationships with ineligible companies.
